Trial intelligence / Profile preview

Conventional bowel preparation versus senna + Pedrolax + bisacodyl for pediatric colonoscopy

IRCT20250426065473N1Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
May 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of sennosides and bisacodyl (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Colon cleansing. Started May 2025; status: completed.

02

Drugs

sennosidesbisacodyl

Beyond the preview

Go deeper on IRCT20250426065473N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250426065473N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call